chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Immediately after removing needle from clients arm, she fainted. Client was placed in a chair with her head down between her legs, two ice packs were placed on her. Clients pulse and blood pressure were monitored. Client remained seated in clinic room from 4:05PM to 4:27PM when she left with her mother.
On Monday 04/25/2022, I thought I was having some seasonal allergies or a head cold. We were going to visit some friends who were expecting a new baby early next week. I went to go get some OTC medication and decided to do an at-home test to be safe. I came back Positive. I did a second test only because my wife tested with me 04/25/2022 and she came back Negative but I came Positive. On Monday, I called my PCP for a Tele-health visit and was prescribed a Z-pack (Azithromycin) and Dexamethasone 4mg. I feel fine which is why I was surprised but I am still testing Positive.
Presents to clinic with swelling of (L) clavicle and under (L) arm. Reports area of painful. Treated by MD with loratadine 10mg daily and MEDROL dose pack. Chest xray also ordered.
high blood pressure, I was having continual  headaches , loss of smell and taste and hair loss, I did not lose my sense of smell and taste when I had COVID-19 in November 15th, 2020.   I never had high blood pressure prior to the vaccination. I am on high blood pressure medication after the vaccine.  I was on BP medication when I took the second dose and my BP still went real high.  I still have loss of taste and smell , and I still have high blood pressure, and I'm still continuing with the headaches.
Information has been received from a nurse referring to an unknown number of patients of unknown age and gender. Information about concurrent conditions and medical history were not provided. On unknown dates the patients were vaccinated with GARDASIL (lot # K007264, expiration date 02-MAR-2017, dose, dose# and route not reported) which were improperly stored. The temperature excursion for GARDASIL was supported with in-house stability data. No information regarding concomitant therapy was provided. No adverse symptoms reported. The outcome of the event was not reported. Additional information has been requested.
Severe headache; Severe arm pain; Chills; Nausea; Diarrhea; Weakness; Muscle pain; Joint pain; Earache; Sore throat; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 14Apr2021 at 16:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, hypothyroidism, uncomplicated diabetes, bipolar disorder, anxiety disorder, acid reflux, irritable bowel syndrome (IBS), penicillin allergy, allergy to citrus and milk allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN); levothyroxine (MANUFACTURER UNKNOWN); glipizide (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN) and unspecified L (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. The patient previously received amitriptyline (MANUFATURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. On 14Apr2021 at 20:00, the patient experienced severe headache, severe arm pain, chills, nausea, diarrhea, weakness, muscle pain, joint pain, earache and sore throat. The events did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe headache, severe arm pain, chills, nausea, diarrhea, weakness, muscle pain, joint pain, earache and sore throat was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Rash - trunk, face, arms, neck. Rash was pruritic, chills, dry cough, hot/cold sweats, nasal congestion/runny nose, red eyes. TX: Recommended OTC BENADRYL or CLARITIN/antihistamine.
generalized tonic clonic seizure, 3 minutes duration. Spontaneous resolution. Complete recovery.
High fever of 102+ controlled with MOTRIN around the clock. Baby will not sleep longer than 30-45 min at a time. Restless or awake all night. Screams and writhes for up to an hour at a time multiple times during the night. Decreased appetite. Decrease in wet diapers. Pale face. Red around eyes. Looks exhausted. Excrement is tan and soft.
Second Shot - 3:30pm on 2/11/21 - 10pm on 2/11/21 extremely sore arm  2/12/21  7am (upon waking): - Tired - Over sensitive to smells (particularly bad ones). Very weird.  - Mild headache - Ringing/white noise in ears - Couldn?t lift arm more than 1 foot from where it hung by my thigh.   11:45am - Started a low grade fever - Having trouble doing my job (couldn?t always form thoughts or do my job)  - left work at 12:15pm - Mild headache and ear issues continued  12:30pm-10pm - Fever between 101.7- 103 (typically closer to 103) - Chills (hands shaking so bad I couldn?t hold things, couldn?t get warm, had to wait for them to subside to text or try and use the remote). It took me 45 minutes to get off the couch to go to the bathroom.  - Ear issues continued  Fell asleep at 10pm and woke at 4:30am on 2/13/21. Was completely soaked. Like if I had stood in the shower with my clothes on. Clothes clung to my body they were soaking and I had lost about 2lbs (obviously in water). Took temperature but no fever.  Went back to bed.   Since waking at 8:30am, I am tired, have a small headache and that is all.
Information has been received from a physician and a practice manager via company representative referring to a patient of unknown age and gender. On 10-APR-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23-10PK-0.5mlSD-PFS LLokwTip) (lot # K019386, expiration date 09-JUN-2016). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 768 hours with the lowest recorded temperature of 27 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
pins and needle like a neuropathy all over the body like face, hands, toe/little spark throughout my body, sparks like fireworks; could not sleep; tingling in feet, hands, chest, knee, quad/pins and needle like a neuropathy all over the body like face, hands, toe; very uncomfortable; This is a spontaneous report from a contactable consumer (patient). A 46-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: FC3184), intramuscularly in the left deltoid (reported as left shoulder) on 09Sep2021 at night (at the age of 46-year-old), dose number unknown, single for COVID-19 immunisation. The patient had no medical history and he was healthy. Concomitant medication included multivitamins supplements. On 09Sep2021, at night, the patient had tingling in his feet, hands, chest, knee, and quad. On 10Sep2021, the patient had same problem, so he went to urgent care and the urgent care sent him to the emergency room. The patient had the same symptoms and first day he thought it was blood pressure, but it was not, and they could not figure out what it was. On 10Sep2021 at night he could not sleep, he had pins and needle like a neuropathy all over his body like face, hands, toe. The patient had blood work done and they checked all his level for everything, they check for everything high blood pressure, diabetes, they check his sugar, they check everything and they still could not figure out anything else, so, he talk to some people on social media and they said that they had same thing for 5 months, 6 months. The patient stated he did not want to be in that situation because he was very uncomfortable. The patient was actually taking off of work because there was little spark throughout his body, sparks like fireworks. The patient stated he do not know if anyone else had reported this, but he wanted to make sure what could be done. The patient stated he want to resolve it, he want to get rid off this. The patient stated he was not on the medication for the events yet because the blood work did not show anything, but he did not try to take something to stop what he have. The outcome of the events was unknown.  No follow-up attempts are possible; No further information is expected.
More than 35 days since first dose was received and still does not have the second; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (More than 35 days since first dose was received and still does not have the second) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 35 days since first dose was received and still does not have the second). At the time of the report, PRODUCT DOSE OMISSION ISSUE (More than 35 days since first dose was received and still does not have the second) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were provided by the reporter  No treatment medication were provided by the reporter
picked up child @ school, has swollen red area @ site or mMR inj w/red dots, has rash (red) non raised, non-itch, on arms, chest, back, & legs;
My 13-year-old son had it [COVID] twice, once after getting two doses of Pfizer.; My 13-year-old son had it [COVID] twice, once after getting two doses of Pfizer.; This is a spontaneous report received from non-contactable reporter(s) (Nurse).  A 13-year-old male patient received BNT162b2 (COMIRNATY), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "My 13-year-old son had it [COVID] twice, once after getting two doses of Pfizer.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive.  Clinical information: Description of Event: Reader of a medical news site posted in the comment section of an article: "My 13-year-old son had it [COVID] twice, once after getting two doses of Pfizer."Name of Product: Comirnaty. Event took place after use of product. No additional information was provided. Event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the information in the case report and a plausible temporal relationship, a possible causal association between the events Covid 19 and Drug ineffective and suspect drug BNT162B2 cannot be excluded.
The dose of Pneumovax expired on 8/4/18 and was administered on 8/8/18.
Pt arrived to ER due to altered mental status with fever from home. She was admitted with COVID-19 pneumonia without hypoxia.
Adverse events: instant tunnel vision, dizziness, bilateral leg weakness with getting up from chair.  Resolved after a few minutes.     General  side effects: Continued fatigue, cold chills, headache, muscle pain, joint pain, nausea, vomiting
Inital headache every day for the first 3 weeks and now Chronic headaches 3x per week
Rash on my arms and torso in small to large patches, that itch. I've had no treatment for it yet.
Patient developed 4 to 5 hours after COVID-19 vaccine Redness and swelling of face, complained of burning sensation Treated with oral steroids and antihistamines.   No problems with shortness of breath, no problems with wheezing No rash at site of injection
AM following inject 4JUN93 malaise, t102 fever PM, 4JUN93 devel hives, congested; mom (RN) gave DPH sx cont; called MD who suggested DPH 2 drops; next AM 5JUN93 rash inc as well as fever; no SOB but congestion cont;
Chills that lasted for hours; Aching from head to feet; severe headache; leg cramps; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), administered in arm right, administration date 26Feb2021 18:30 (Lot number: EN6023) at the age of 67 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "Headache" (unspecified if ongoing); "Penicillin allergy" (unspecified if ongoing); "COVID-19" (unspecified if ongoing). The patient took concomitant medications. Past drug history included: Aspirin, reaction(s): "Allergy".  The following information was reported: CHILLS (non-serious) with onset 27Feb2021 18:15, outcome "recovered" (28Feb2021), described as "Chills that lasted for hours"; PAIN (non-serious) with onset 27Feb2021 18:15, outcome "recovered" (28Feb2021), described as "Aching from head to feet"; HEADACHE (non-serious) with onset 27Feb2021 18:15, outcome "recovered" (28Feb2021), described as "severe headache"; MUSCLE SPASMS (non-serious) with onset 27Feb2021 18:15, outcome "recovered" (28Feb2021), described as "leg cramps". Therapeutic measures were not taken as a result of chills, pain, headache, muscle spasms.  Additional information: Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had been taking concomitant medications, but the medication name was not reported. The patient did not receive any other vaccines within four weeks prior to COVID vaccination.  No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and drug reactions/allergies were not reported. On an unknown date, the patient was vaccinated with a dose of GARDASIL Lot # M011117, expiration date: 12-JUL-2017 (strength, dose, frequency and route of administration were not reported), or with a dose of ROTATEQ orally, Lot # L033549, expiration date: 05-JUN-2017 (strength, dose and frequency were not reported), which underwent a temperature excursion of 35 Fahrenheit degrees, for 20 minutes and was administered to the patient. No adverse effects were reported by the patient. Additional information is not expected, because no consent for follow-up was provided or physician's contact details.
Grand mal seizures. No hx of seizures in family or patient.  Patient diagnosed w/epilepsy with no know cause.
Information has been received from a physician concerning a 14 year old male with no pertinent medical history and no drug allergies who was vaccinated intramuscularly with the first and second 0.5ml dose of GARDASIL (Lot# not reported) respectively on 02-APR-2012 and 04-JUN-2012. There was no concomitant medication. On 07-JUN-2012 the patient committed suicide. He shot himself in head. Physician stated this young male was happy go lucky, healthy, and never had any psychiatric issues in the past. It was not known if the patient sought for medical attention. On 07-JUN-2012 the patient died of suicide. Additional information has been requested.
Pt stated that she was feeling a tickle in her throat 10 minutes after administration of the vaccine. Pt stated that her throat is dry and feels a sensation to cough. Pt stated that started feeling swelling of the tongue 30 minutes after administration of the vaccine. Pt was given water and says that it helped relieve itching. Pt was given benadryl 25mg IM and is being monitored. Charge nurse is taking over monitoring  and care of patient.
Headache; ear pain, almost like a shooting pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 27Jan2021 09:30 (Lot number: E23247) as dose 1, single and intramuscular, administered in arm left, administration date 16Feb2021 14:00 (Lot number: E23247) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: EAR PAIN (non-serious) with onset 27Jan2021 10:15, outcome "recovered" (Jan2021), described as "ear pain, almost like a shooting pain"; HEADACHE (non-serious) with onset 27Jan2021 18:00, outcome "recovered" (Jan2021), described as "Headache". Therapeutic measures were not taken as a result of ear pain, headache.  Additional information: Prior Vaccinations, concomitant drugs, patient medical history and relevant tests were reported as None. Ear pain almost like a shooting pain about 3 times ober a few minute period shortly after 1st vaccination. It resolved and did not return the headache started in the evening after 1st vaccination and resolved the following day.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021176741 same reporter/patient/drug, different dose
Moderna covid 19 vaccine EUA   10 minutes post vaccine administration I experienced severe nausea, vomiting and loss of consciousness temporarily. I did not require an epi pen but did require anti histamines
Fever 3 days after administration; followed by profound unilateral hearing loss 12/10/2007. 3/26/08-records received-for DOS 12/10/07-Complete loss of hearing left ear, onset uncertain.  DX: conductive hearing loss unilateral. Migraine.
At the time of vaccination, I was around 1 month pregnant. When my son was 3 months old, it was discovered that he had a blood clot (DVT) in his right leg. A work up was done to determine if he had any genetic or autoimmune diseases, as well as any blood clotting disorders. All tests came back negative. Additionally, there was no trauma to his leg. Our understanding is that this is an extremely rare outcome. The cause of the DVT is unknown, but our pediatrician thought there was an outside chance it could have possibly been provoked by the vaccine given its known, albeit rare, blood clotting side effects.
NAUSEA; DIZZINESS; SEVERE LEFT ARM PAIN; EXTREME WEAKNESS OF LEFT ARM - UNABLE TO LIFT ARM (HAD TO USE RIGHT ARM TO LIFT LEFT ARM); DISORIENTATION AND STAGGERING; URGENCY TO URINATE; IRREGULAR HEART BEAT & INCREASED BLOOD PRESSURE, PER EMS; TRANSPORTED TO HOSPITAL ER; RECEIVED IV FLUIDS & TORADOL DURING ER VISIT; SYMPTOMS SUBSIDED DURING ER STAY; DISCHARGED TO HOME FROM ER A FEW HOURS LATER; WEAKNESS AND PAIN IN LEFT ARM GRADUALLY DECREASED OVER NEXT FEW DAYS.
stomach feels bad; doesn't feel well; feels like she has the flu; headache; sore arm where she got the injection; throwing up; nausea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach feels bad), MALAISE (doesn't feel well), INFLUENZA LIKE ILLNESS (feels like she has the flu), HEADACHE (headache) and VACCINATION SITE PAIN (sore arm where she got the injection) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020V21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure. Concomitant products included DILTIAZEM for Blood pressure high.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach feels bad), MALAISE (doesn't feel well), INFLUENZA LIKE ILLNESS (feels like she has the flu), HEADACHE (headache), VACCINATION SITE PAIN (sore arm where she got the injection), VOMITING (throwing up) and NAUSEA (nausea). At the time of the report, ABDOMINAL DISCOMFORT (stomach feels bad), MALAISE (doesn't feel well), VACCINATION SITE PAIN (sore arm where she got the injection), VOMITING (throwing up) and NAUSEA (nausea) was resolving and INFLUENZA LIKE ILLNESS (feels like she has the flu) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Apr-2021, Blood pressure measurement: unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was able to take her blood pressure medication. The patient was taking Zofran and Compazine for the nausea.
Headache, Myalgia, NauseaVomiting, LOW GRADE FEVER,CHILLS Narrative:
Red, smooth rash on both cheeks and nose; slightly itchy; pt took BENADRYL on Fri night & Sat. rash is improving.
Widespread erythema multiforme rash following localized swelling to injection site day prior which had resolved within a few hours. Did not respond to Benadryl. Also had mild joint swelling to bilateral ankles. Resolved in < 72 hours without lasting impact.
On 4/1/21, I was determined to have lymphocytosis.  It had not been present on three previous CBC's in the last months of 2020.  On 7/2/21, the lymphocytosis had worsened, and I was determined to have Monoclonal B Cell Lymphocytosis - CLL type.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications.  On an unknown date in 2009, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route of administration were not specified) for the long-term prevention of shingles and zoster-related conditions, by a pharmacist in a pharmacy. On an unspecified date, the patient experienced shingles. On an unspecified date, the patient was treated by a healthcare provider for shingles. As a direct and proximate result of the patient's use of the zoster vaccine live (ZOSTAVAX) vaccine, the patient had and would continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future  The outcome of the event of shingles was not reported. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).